UC San Diego team flags catestatin peptide as dementia target
Researchers say the naturally occurring fragment appears to interfere with processes driving brain cell loss, but safety and dosing are unstudied.
PR
By Priya Raman · Science Reporter
Sep 25 14:10 ETSource: Q104.3
The wire
- 01Researchers at the University of California, San Diego School of Medicine identified catestatin, a naturally occurring peptide they report may help prevent processes leading to loss of brain cells.
- 02Catestatin joins the list of endogenous peptide fragments being examined as candidate therapies for Alzheimer's and other neurodegenerative disease.
- 03The authors emphasize that safety, dosing and effectiveness remain undetermined and further study is needed before any human use; this radio report gives no study details or model.
From the source
Read at q1043.iheart.comResearchers Discover Peptide That Could Target Dementia | Q104.3 | Jonathan 'JC' Clarke
Researchers at the University of California, San Diego School of Medicine have identified a naturally occurring peptide that shows potential in combating Alzheimer's and other neurodegenerative diseases. The small protein fragment, known as catestatin (CST), may help prevent processes leading to the loss of brain cells, which can cause symptoms like memory loss and confusion.
